Rani Therapeutics
RANI
RANI
42 hedge funds and large institutions have $5.23M invested in Rani Therapeutics in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
8.71% less ownership
Funds ownership: 20.18% → 11.47% (-8.7%)
44% less call options, than puts
Call options by funds: $157K | Put options by funds: $279K
59% less capital invested
Capital invested by funds: $12.8M → $5.23M (-$7.53M)
Holders
42
Holding in Top 10
2
Calls
$157K
Puts
$279K
Top Buyers
| 1 | +$399K | |
| 2 | +$164K | |
| 3 | +$151K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$126K |
| 5 |
IAS
Insigneo Advisory Services
Miami,
Florida
|
+$65.1K |
Top Sellers
| 1 | -$5.56M | |
| 2 | -$349K | |
| 3 | -$71.7K | |
| 4 |
Luther King Capital Management (LKCM)
Fort Worth,
Texas
|
-$65.9K |
| 5 |
Millennium Management
New York
|
-$24.7K |